Willow vs Strut Health: Oral GLP-1 and Support Compared
Quick comparison and verdict
Willow vs Strut Health pits Willow’s structured oral GLP-1 program with progress tracking and follow-up against Strut Health’s oral semaglutide specialization and lower starting price. Early verdict: choose Willow for structured follow-up and behavior-focused tracking, choose Strut Health for lower starting cost and an oral semaglutide focus.
Explore Willow’s tracked program
Five key differences at a glance
| Criteria | Willow | Strut Health |
|---|---|---|
| Starting price | $299 (starting price reported) | From $199 per Month (from $199/month) |
| Treatment focus | Oral GLP-1 program presented as a structured weight management journey | Oral semaglutide specialization and oral-based program options |
| Clinical support | Licensed telehealth team, progress tracking tools, follow-up consultations | Guided consultations and ongoing progress communication |
| Compounded medication note | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
| Best for | Users who want structured digital follow-up | Users specifically seeking oral plans |
Pricing and value
Price is a clear contrast in the Willow vs Strut Health comparison. Willow lists a starting price of 299 while Strut Health advertises plans from $199 per month. The source evidence reports Willow as having a higher monthly entry price for some plans and Strut Health as emphasizing a lower starting cost and no hidden fees on its landing content. No further membership, shipping, cancellation, or discount details were verified for Willow on the captured page.
See Strut Health pricing and options
Treatment focus and formulation
Both providers focus on oral GLP-1 approaches, but with different emphases. Willow positions an oral GLP-1 program as a structured weight management journey that pairs medication with progress tracking and follow-up support. Strut Health centers on oral semaglutide specifically, offering lozenges and oral-based options and explaining how semaglutide may work and how lozenges are taken once daily.
Clinical support and follow-up
Willow highlights a licensed telehealth team plus progress tracking tools and follow-up consultations intended to turn GLP-1 efficacy into sustainable outcomes. Strut Health emphasizes guided consults and ongoing progress communication and notes clinical requirements such as medical necessity for compounded semaglutide. Both report licensed clinicians are involved and that treatment is available only when clinically appropriate or medically necessary subject to clinician review.
Check Willow’s clinician-led program
Compounded medication and regulatory notes
In this Willow vs Strut Health comparison both sources include regulatory cautions: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Strut Health adds that compounded semaglutide is prescribed based on medical necessity and is available only for patients that fail or cannot use commercially available GLP-1 medications. Willow’s evidence notes that compounded medications, when offered, are not FDA-approved and must be distinguished from branded products.
Who each provider is best for
Choose Willow if you want structured digital follow-up, licensed telehealth support, and progress tracking as part of an oral GLP-1 weight management journey.
Choose Strut Health if you are specifically seeking oral semaglutide options, lower starting pricing from $199 per month, and a provider focused on oral medication management.
Explore Strut Health oral plans
Final note: this Willow vs Strut Health comparison uses only captured source details. Treatment availability is subject to licensed clinician review and compounded medications are not FDA-reviewed for safety, effectiveness or quality.